High risks associated with the transmission of infectious diseases to pregnant women have raised concerns about the effective diagnosis of various infections. As such, the infectious disease testing type segment of the women’s health diagnostics market is projected to reach a value of ~US$ 19.2 Bn by the end of 2027. Hence, leading players in the market for women’s health diagnostics are increasing their efficacy in laboratory testing solutions to improve patient outcomes. For instance, leading global medical technology company Siemens Healthineers offers a range of laboratory testing solutions for women related to TORCH (toxoplasmosis, other (e.g., syphilis, HIV), rubella, cytomegalovirus (CMV), and herpes simplex virus) infections, malnutrition, and bone diseases.
Healthcare companies in the women’s health diagnostics market are tapping into opportunities in diagnostic laboratory testing and infectious disease testing, as both segments are anticipated to grow rapidly during the forecast period. The growing prevalence of infections causing miscarriage and birth defects in infants is fueling the demand for efficacious treatment options in women’s health diagnostics.
Apart from expanding product portfolios, companies in the market for women’s health diagnostics are strengthening their global presence through inorganic strategies such as mergers and acquisitions. For instance, in August 2019, Nova Satra Dx - a provider of innovative diagnostics for cancer, announced its merger with a Singapore-based molecular diagnostic company INEX Innovations Exchange Pte. Ltd., to offer healthcare solutions tailored for Asian women. As such, Asia Pacific accounts for the third-highest revenue in the women’s health diagnostics market. This market in the Asia Pacific is anticipated for exponential growth during the forecast period.
Companies are collaborating to offer enhanced treatment options in the Asia Pacific. Efforts are being made to increase the availability of faster and more accurate diagnostic tests to improve the quality of life in patients. The concept of precision healthcare is another key driver that is creating incremental opportunities for companies. The women’s health diagnostics industry is undergoing change with increased efforts toward providing women’s reproductive health solutions.
New Testing Approaches Create Revenue Opportunities for Companies and Healthcare Providers
Complications associated with cervical cancer have led to the availability of new tests for early detection of the human papillomavirus (HPV). As such, in terms of test type, the cervical cancer testing segment of the women’s health diagnostics market is estimated to reach a value of ~US$ 12.5 Bn by 2027. Hence, companies are introducing new testing options to determine the type of HPV that may lead to cancer.
Get a glimpse of the in-depth analysis through our Report Brochure
Companies in the women’s health diagnostics business are increasing R&D to study the ‘two-for-one’ diagnostic approach that not only detects the type of HPV infection but also evaluates precancerous makers. Patients are increasingly benefitting from this approach since it serves as a low-cost alternative to diagnose the riskiest forms of HPV infection. Thus, to cater to the convenience of patients, companies in the market for women’s health diagnostics are collaborating with research labs to improve outcomes that help to avoid unnecessary diagnostic procedures. Moreover, healthcare providers are increasing efficacy in novel in-vitro molecular diagnostics procedures to assess high-risk HPV infections.
Diagnostic laboratory centers are collaborating with renowned universities to introduce new combined HIV/syphilis testing options. For instance, Junco Labs - a provider of smartphone diagnostics, revealed its collaboration with Columbia University to demonstrate the integration of smartphone-connected blood tests for combined HIV/syphilis tests.
Thus, the diagnostic laboratories & imaging centers end-user segment of the women’s health diagnostics market is expected to reach a value of ~US$ 20.7 Bn by 2022. Hence, stakeholders in diagnostic labs are seeking innovations in dual HIV/syphilis tests.
In the global market, efforts are being made to increase the availability of point-of-care (POC) treatments for women. Companies in the women’s health diagnostics business are introducing novel testing options that provide qualitative detection of non-TP (Treponema Pallidum) syphilis. However, there is still a need for effective HIV/syphilis testing options that align with the existing target product profile (TPP). Companies in the market for women’s health diagnostics are offering cost-effective and easy-to-assess tests for combined HIV/syphilis diagnosis.
Expanding operations in the future? To get the perfect launch to ask for a custom report
Analysts’ Viewpoint
Companies in the women’s health diagnostics market are offering increased laboratory testing options to assess biomarkers for allergies, thyroid, and renal diseases in women. Companies should increase focus on expansion of diagnostic services in growing economies of Asia Pacific such as Indonesia and Bangladesh.
However, challenges such as poor supply chain management and stock-outs of POC diagnostic tests in developing economies, such as Ghana, pose as a challenge for manufacturing companies. Hence, companies should adopt inventory management techniques and aid health commissions to increase the human resource capacity for ensuring accessibility and sustainability toward POC testing in resource-limited settings.
Major Players in Global Market
Women’s Health Diagnostics Market – Segmentation
|
Device Type |
Biopsy Devices Imaging & Monitoring Systems
Kits & Reagents Consumables & Accessories |
|
Test Type |
Breast Cancer Testing Cervical Cancer Testing Prenatal Genetic Screening & Carrier Testing Pregnancy Testing Fertility & Ovulation Testing Infectious Disease Testing Others |
|
End User |
Hospitals Diagnostic Laboratories & Imaging Centers Specialty Clinics Others |
|
Region |
North America Europe Asia Pacific Latin America Middle East & Africa |
The global market for Women’s health diagnostics is projected to reach a value of ~US$ 19.2 Bn by the end of 2027
The market is projected to expand at a CAGR of ~6% from 2019 to 2027
Women’s health diagnostics market is driven by increase in awareness among people about the availability of treatments for sexually transmitted diseases
The end-use segments in women’s health diagnostics market are hospitals, diagnostic laboratories & imaging centers and specialty clinics
Key players in the global market for women’s health diagnostics include Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, F. Hoffmann-La Roche AG
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. 3. Executive Summary: Global Women’s Health Diagnostics Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Women’s Health Diagnostics Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Global Women’s Health Diagnostics Market Analysis and Forecast, by Device Type
5.1. Introduction
5.2. Key Findings
5.3. Global Women’s Health Diagnostics Market Value Forecast, by Device Type, 2017–2027
5.3.1. Biopsy Devices
5.3.2. Imaging & Monitoring System
5.3.2.1. Ultrasound Devices
5.3.2.2. Mammography Systems
5.3.2.3. MRI Systems
5.3.2.4. Others
5.3.3. Kits & Reagents
5.3.4. Consumables & Accessories
5.4. Global Women’s Health Diagnostics Market Attractiveness, by Device Type
6. Global Women’s Health Diagnostics Market Analysis and Forecast, by Test Type
6.1. Introduction & Definition
6.2. Key Findings
6.3. Global Women’s Health Diagnostics Market Value Forecast, by Test Type, 2017–2027
6.3.1. Breast Cancer Testing
6.3.2. Cervical Cancer Testing
6.3.3. Prenatal Genetic Screening & Carrier Testing
6.3.4. Pregnancy Testing
6.3.5. Fertility & Ovulation Testing
6.3.6. Infectious Disease Testing
6.3.7. Others
6.4. Global Women’s Health Diagnostics Market Attractiveness, by Test Type
7. Global Women’s Health Diagnostics Market Analysis and Forecast, by End-user
7.1. Introduction
7.2. Key Findings
7.3. Global Women’s Health Diagnostics Market Value Forecast, by End-user, 2017–2027
7.3.1. Hospitals
7.3.2. Diagnostic Laboratories & Imaging Centers
7.3.3. Specialty Clinics
7.3.4. Others
7.4. Global Women’s Health Diagnostics Market Attractiveness, by End-user
8. Global Women’s Health Diagnostics Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Women’s Health Diagnostics Market Value Forecast, by Region, 2017–2027
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Women’s Health Diagnostics Market Attractiveness, by Region
9. North America Women’s Health Diagnostics Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America Women’s Health Diagnostics Market Value Forecast, by Device Type, 2017–2027
9.2.1. Biopsy Devices
9.2.2. Imaging & Monitoring System
9.2.2.1. Ultrasound Devices
9.2.2.2. Mammography Systems
9.2.2.3. MRI Systems
9.2.2.4. Others
9.2.3. Kits & Reagents
9.2.4. Consumables & Accessories
9.3. North America Women’s Health Diagnostics Market Value Forecast, by Test Type, 2017–2027
9.3.1. Breast Cancer Testing
9.3.2. Cervical Cancer Testing
9.3.3. Prenatal Genetic Screening & Carrier Testing
9.3.4. Pregnancy Testing
9.3.5. Fertility & Ovulation Testing
9.3.6. Infectious Disease Testing
9.3.7. Others
9.4. North America Women’s Health Diagnostics Market Value Forecast, by End-user, 2017–2027
9.4.1. Hospitals
9.4.2. Diagnostic Laboratories & Imaging Centers
9.4.3. Specialty Clinics
9.4.4. Others
9.5. North America Women’s Health Diagnostics Market Value Forecast, by Country, 2017–2027
9.5.1. U.S.
9.5.2. Canada
9.6. North America Women’s Health Diagnostics Market Attractiveness Analysis
9.6.1. By Device Type
9.6.2. By Test Type
9.6.3. By End-user
9.6.4. By Country
10. Europe Women’s Health Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Europe Women’s Health Diagnostics Market Value Forecast, by Device Type, 2017–2027
10.2.1. Biopsy Devices
10.2.2. Imaging & Monitoring System
10.2.2.1. Ultrasound Devices
10.2.2.2. Mammography Systems
10.2.2.3. MRI Systems
10.2.2.4. Others
10.2.3. Kits & Reagents
10.2.4. Consumables & Accessories
10.3. Europe Women’s Health Diagnostics Market Value Forecast, by Test Type, 2017–2027
10.3.1. Breast Cancer Testing
10.3.2. Cervical Cancer Testing
10.3.3. Prenatal Genetic Screening & Carrier Testing
10.3.4. Pregnancy Testing
10.3.5. Fertility & Ovulation Testing
10.3.6. Infectious Disease Testing
10.3.7. Others
10.4. Europe Women’s Health Diagnostics Market Value Forecast, by End-user, 2017–2027
10.4.1. Hospitals
10.4.2. Diagnostic Laboratories & Imaging Centers
10.4.3. Specialty Clinics
10.4.4. Others
10.5. Europe Women’s Health Diagnostics Market Value Forecast, by Country/Sub-region, 2017–2027
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Spain
10.5.5. Italy
10.5.6. Rest of Europe
10.6. Europe Women’s Health Diagnostics Market Attractiveness Analysis
10.6.1. By Device Type
10.6.2. By Test Type
10.6.3. By End-user
10.6.4. By Country/Sub-region
11. Asia Pacific Women’s Health Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Asia Pacific Women’s Health Diagnostics Market Value Forecast, by Device Type, 2017–2027
11.2.1. Biopsy Devices
11.2.2. Imaging & Monitoring System
11.2.2.1. Ultrasound Devices
11.2.2.2. Mammography Systems
11.2.2.3. MRI Systems
11.2.2.4. Others
11.2.3. Kits & Reagents
11.2.4. Consumables & Accessories
11.3. Asia Pacific Women’s Health Diagnostics Market Value Forecast, by Test Type, 2017–2027
11.3.1. Breast Cancer Testing
11.3.2. Cervical Cancer Testing
11.3.3. Prenatal Genetic Screening & Carrier Testing
11.3.4. Pregnancy Testing
11.3.5. Fertility & Ovulation Testing
11.3.6. Infectious Disease Testing
11.3.7. Others
11.4. Asia Pacific Women’s Health Diagnostics Market Value Forecast, by End-user, 2017–2027
11.4.1. Hospitals
11.4.2. Diagnostic Laboratories & Imaging Centers
11.4.3. Specialty Clinics
11.4.4. Others
11.5. Asia Pacific Women’s Health Diagnostics Market Value Forecast, by Country/Sub-region, 2017–2027
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Asia Pacific Women’s Health Diagnostics Market Attractiveness Analysis
11.6.1. By Device Type
11.6.2. By Test Type
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Latin America Women’s Health Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Latin America Women’s Health Diagnostics Market Value Forecast, by Device Type, 2017–2027
12.2.1. Biopsy Devices
12.2.2. Imaging & Monitoring System
12.2.2.1. Ultrasound Devices
12.2.2.2. Mammography Systems
12.2.2.3. MRI Systems
12.2.2.4. Others
12.2.3. Kits & Reagents
12.2.4. Consumables & Accessories
12.3. Latin America Women’s Health Diagnostics Market Value Forecast, by Test Type, 2017–2027
12.3.1. Breast Cancer Testing
12.3.2. Cervical Cancer Testing
12.3.3. Prenatal Genetic Screening & Carrier Testing
12.3.4. Pregnancy Testing
12.3.5. Fertility & Ovulation Testing
12.3.6. Infectious Disease Testing
12.3.7. Others
12.4. Latin America Women’s Health Diagnostics Market Value Forecast, by End-user, 2017–2027
12.4.1. Hospitals
12.4.2. Diagnostic Laboratories & Imaging Centers
12.4.3. Specialty Clinics
12.4.4. Others
12.5. Latin America Women’s Health Diagnostics Market Attractiveness Analysis
12.5.1. By Device Type
12.5.2. By Test Type
12.5.3. By End-user
12.5.4. By Country/Sub-region
13. Middle East & Africa Women’s Health Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Middle East & Africa Women’s Health Diagnostics Market Value Forecast, by Device Type, 2017–2027
13.2.1. Biopsy Devices
13.2.2. Imaging & Monitoring System
13.2.2.1. Ultrasound Devices
13.2.2.2. Mammography Systems
13.2.2.3. MRI Systems
13.2.2.4. Others
13.2.3. Kits & Reagents
13.2.4. Consumables & Accessories
13.3. Middle East & Africa Women’s Health Diagnostics Market Value Forecast, by Test Type, 2017–2027
13.3.1. Breast Cancer Testing
13.3.2. Cervical Cancer Testing
13.3.3. Prenatal Genetic Screening & Carrier Testing
13.3.4. Pregnancy Testing
13.3.5. Fertility & Ovulation Testing
13.3.6. Infectious Disease Testing
13.3.7. Others
13.4. Middle East & Africa Women’s Health Diagnostics Market Value Forecast, by End-user, 2017–2027
13.4.1. Hospitals
13.4.2. Diagnostic Laboratories & Imaging Centers
13.4.3. Specialty Clinics
13.4.4. Others
13.5. Middle East & Africa Women’s Health Diagnostics Market Value Forecast, by Country/Sub-region, 2017–2027
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Middle East & Africa Women’s Health Diagnostics Market Attractiveness Analysis
13.6.1. By Device Type
13.6.2. By Test Type
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Competition Landscape
14.1. Market Players - Competition Matrix (By Tier and Size of companies)
14.2. Market Share Analysis, by Company, 2018
14.3. Company Profiles
14.3.1. Abbott Laboratories
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Becton, Dickinson and Company
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Overview
14.3.2.3. Product Portfolio
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. bioMérieux SA
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Overview
14.3.3.3. Product Portfolio
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. F. Hoffmann-La Roche AG
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Financial Overview
14.3.4.3. Product Portfolio
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. GE Healthcare
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Financial Overview
14.3.5.3. Product Portfolio
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Hologic, Inc.
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Overview
14.3.6.3. Product Portfolio
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Koninklijke Philips N.V.
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Financial Overview
14.3.7.3. Product Portfolio
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Quest Diagnostics, Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Overview
14.3.8.3. Product Portfolio
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Cardinal Health
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Financial Overview
14.3.9.3. Product Portfolio
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. Siemens AG
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Financial Overview
14.3.10.3. Product Portfolio
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
List of Tables
Table 01: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017–2027
Table 02: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring Systems, 2017–2027
Table 03: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
Table 04: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 05: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 06: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 07: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017–2027
Table 08: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring System
Table 09: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
Table 10: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 11: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 12: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017–2027
Table 13: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring System
Table 14: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
Table 15: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 16: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 17: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017–2027
Table 18: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring System
Table 19: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
Table 20: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 21: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 22: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017–2027
Table 23: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring System
Table 24: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
Table 25: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 26: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 27: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017–2027
Table 28: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring System
Table 29: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
Table 30: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027
List of Figures
Figure 01: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, 2017–2027
Figure 02: Global Women's Health Diagnostics Market Value Share by Device Type (2018)
Figure 03: Global Women's Health Diagnostics Market Value Share by End-users (2018)
Figure 04: Global Women's Health Diagnostics Market Value Share by Test Type (2018)
Figure 05: Global Women's Health Diagnostics Market Value Share by Region (2018)
Figure 06: Global Women's Health Diagnostics Market Value Share, by Device Type, 2018 and 2027
Figure 07: Global Women's Health Diagnostics Market Attractiveness, by Device Type, 2018
Figure 08: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Biopsy Devices, 2017–2027
Figure 09: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Imaging and Monitoring Systems, 2017–2027
Figure 10: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Kits & Reagents, 2017–2027
Figure 11: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Consumables & Accessories, 2017–2027
Figure 12: Global Women's Health Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027
Figure 13: Global Women's Health Diagnostics Market Attractiveness Analysis, by Test Type, 2018
Figure 14: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Breast Cancer Testing, 2017–2027
Figure 15: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Cervical Cancer Testing, 2017- 2027
Figure 16: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Prenatal Genetic Screening and Carrier Testing, 2017–2027
Figure 17: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Pregnancy Testing, 2017- 2027
Figure 18: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Fertility and Ovulation Testing, 2017–2027
Figure 19: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Infectious Disease Testing, 2017- 2027
Figure 20: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027
Figure 21: Global Women's Health Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
Figure 22: Global Women's Health Diagnostics Market Attractiveness Analysis, by End-user, 2018
Figure 23: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027
Figure 24: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories & Imaging Centers, 2017–2027
Figure 25: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Specialty Clinics, 2017–2027
Figure 26: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027
Figure 27: Global Women's Health Diagnostics Market Value Share Analysis, by Region, 2018 and 2027
Figure 28: Global Women's Health Diagnostics Market Attractiveness Analysis, by Region, 2018
Figure 29: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, 2017–2027
Figure 30: North America Women's Health Diagnostics Market Attractiveness Analysis, by Country, 2018
Figure 31: North America Women's Health Diagnostics Market Value Share Analysis, by Country, 2018 and 2027
Figure 32: North America Women's Health Diagnostics Market Value Share Analysis, by Device Type, 2018 and 2027
Figure 33: North America Women's Health Diagnostics Market Attractiveness, by Device Type, 2018
Figure 34: North America Women's Health Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027
Figure 35: North America Women's Health Diagnostics Market Attractiveness Analysis, by Test Type, 2018
Figure 36: North America Women's Health Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
Figure 37: North America Women's Health Diagnostics Market Attractiveness Analysis, by End-user, 2018
Figure 38: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, 2017–2027
Figure 39: Europe Women's Health Diagnostics Market Attractiveness, by Country/Sub-region, 2018
Figure 40: Europe Women's Health Diagnostics Market Value Share, by Country/Sub-region, 2018 and 2027
Figure 41: Europe Women's Health Diagnostics Market Value Share Analysis, by Device Type, 2018 and 2027
Figure 42: Europe Women's Health Diagnostics Market Attractiveness, by Device Type, 2018
Figure 43: Europe Women's Health Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027
Figure 44: Europe Women's Health Diagnostics Market Attractiveness Analysis, by Test Type, 2018
Figure 45: Europe Women's Health Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
Figure 46: Europe Women's Health Diagnostics Market Attractiveness Analysis, by End-user, 2018
Figure 47: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, 2017–2027
Figure 48: Asia Pacific Women's Health Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2018
Figure 49: Asia Pacific Women's Health Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 50: Asia Pacific Women's Health Diagnostics Market Value Share Analysis, by Device Type, 2018 and 2027
Figure 51: Asia Pacific Women's Health Diagnostics Market Attractiveness, by Device Type, 2018
Figure 52: Asia Pacific Women's Health Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027
Figure 53: Asia Pacific Women's Health Diagnostics Market Attractiveness Analysis, by Test Type, 2018
Figure 54: Asia Pacific Women's Health Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
Figure 55: Asia Pacific Women's Health Diagnostics Market Attractiveness Analysis, by End-user, 2018
Figure 56: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, 2017–2027
Figure 57: Latin America Women's Health Diagnostics Market Attractiveness, by Country/Sub-region, 2018
Figure 58: Latin America Women's Health Diagnostics Market Value Share, by Country/Sub-region, 2018 and 2027
Figure 59: Latin America Women's Health Diagnostics Market Value Share Analysis, by Device Type, 2018 and 2027
Figure 60: Latin America Women's Health Diagnostics Market Attractiveness, by Device Type, 2018
Figure 61: Latin America Women's Health Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027
Figure 62: Latin America Women's Health Diagnostics Market Attractiveness Analysis, by Test Type, 2018
Figure 63: Latin America Women's Health Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
Figure 64: Latin America Women's Health Diagnostics Market Attractiveness Analysis, by End-user, 2018
Figure 65: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, 2017–2027
Figure 66: Middle East & Africa Women's Health Diagnostics Market Attractiveness, by Country/Sub-region, 2018
Figure 67: Middle East & Africa Women's Health Diagnostics Market Value Share, by Country/Sub-region, 2018 and 2027
Figure 68: Middle East & Africa Women's Health Diagnostics Market Value Share Analysis, by Device Type, 2018 and 2027
Figure 69: Middle East & Africa Women's Health Diagnostics Market Attractiveness, by Device Type, 2018
Figure 70: Middle East & Africa Women's Health Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027
Figure 71: Middle East & Africa Women's Health Diagnostics Market Attractiveness Analysis, by Test Type, 2018
Figure 72: Middle East & Africa Women's Health Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
Figure 73: Middle East & Africa Women's Health Diagnostics Market Attractiveness Analysis, by End-user, 2018
Figure 74: Global Women's Health Diagnostics Market Share Analysis, by Company (2018)
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Women’s Health Diagnostics Market
*86 figures and 60 tables includes